Crossbow Therapeutics
Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers
$77MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers
Pitching LifeLink Ventures? Send the deck from a free RoundOS data room and see which pages they read.